Susan Patalano

509 total citations
13 papers, 216 citations indexed

About

Susan Patalano is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Susan Patalano has authored 13 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Susan Patalano's work include Prostate Cancer Treatment and Research (9 papers), Epigenetics and DNA Methylation (5 papers) and Ubiquitin and proteasome pathways (3 papers). Susan Patalano is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Epigenetics and DNA Methylation (5 papers) and Ubiquitin and proteasome pathways (3 papers). Susan Patalano collaborates with scholars based in United States, Canada and China. Susan Patalano's co-authors include Jill A. Macoska, Shuai Gao, Dong Han, Changmeng Cai, Housheng Hansen He, Wanting Han, Diego Almanza, Steven P. Balk, Eva Corey and Mehrnaz Gharaee‐Kermani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Susan Patalano

12 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Patalano United States 9 128 107 48 40 14 13 216
Pedro Oliveira United Kingdom 6 72 0.6× 114 1.1× 28 0.6× 34 0.8× 13 0.9× 14 155
Ojasvi Chaudhary United States 2 79 0.6× 93 0.9× 51 1.1× 54 1.4× 22 1.6× 2 173
Yuman He China 8 92 0.7× 63 0.6× 58 1.2× 41 1.0× 29 2.1× 12 178
Eliot Linton United States 1 77 0.6× 93 0.9× 50 1.0× 52 1.3× 21 1.5× 2 170
Zixin Guo China 9 111 0.9× 129 1.2× 99 2.1× 59 1.5× 14 1.0× 19 220
France‐Hélène Joncas Canada 7 201 1.6× 62 0.6× 69 1.4× 35 0.9× 28 2.0× 15 286
Hai Jiang China 8 232 1.8× 39 0.4× 76 1.6× 46 1.1× 12 0.9× 18 333
Rebiguli Aji China 4 68 0.5× 65 0.6× 50 1.0× 65 1.6× 17 1.2× 7 164
Jinyeong Lim South Korea 7 76 0.6× 42 0.4× 46 1.0× 37 0.9× 18 1.3× 18 157
Hai Tao Wang China 5 103 0.8× 186 1.7× 78 1.6× 63 1.6× 10 0.7× 12 258

Countries citing papers authored by Susan Patalano

Since Specialization
Citations

This map shows the geographic impact of Susan Patalano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Patalano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Patalano more than expected).

Fields of papers citing papers by Susan Patalano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Patalano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Patalano. The network helps show where Susan Patalano may publish in the future.

Co-authorship network of co-authors of Susan Patalano

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Patalano. A scholar is included among the top collaborators of Susan Patalano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Patalano. Susan Patalano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Han, Wanting, Nancy Patten, Susan Patalano, et al.. (2025). Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells. Molecular Cancer Therapeutics. 24(5). 772–783.
2.
Wang, Zifeng, Scott L. Townley, Mu‐Qing Li, et al.. (2024). FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer. Nature Communications. 15(1). 4914–4914. 13 indexed citations
3.
Han, Wanting, Zifeng Wang, Susan Patalano, et al.. (2023). Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression. Cancer Research Communications. 3(8). 1716–1730. 1 indexed citations
4.
Han, Wanting, Zifeng Wang, Dong Han, et al.. (2023). LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer. Cancer Research. 83(10). 1684–1698. 52 indexed citations
5.
Wang, Zifeng, Jessica Petricca, Sujun Chen, et al.. (2023). SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1. Proceedings of the National Academy of Sciences. 120(33). e2220472120–e2220472120. 9 indexed citations
6.
Patalano, Susan, et al.. (2023). A Bayesian noisy logic model for inference of transcription factor activity from single cell and bulk transcriptomic data. NAR Genomics and Bioinformatics. 5(4). lqad106–lqad106. 2 indexed citations
7.
Han, Wanting, Dong Han, Zifeng Wang, et al.. (2022). RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition. Oncogene. 41(6). 852–864. 26 indexed citations
8.
Han, Wanting, Dong Han, Zifeng Wang, et al.. (2022). Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer. Molecular Therapy. 30(4). 1628–1644. 25 indexed citations
9.
Li, Mu‐Qing, Lily Ting, Shuai Gao, et al.. (2022). Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2. Frontiers in Oncology. 12. 1021845–1021845. 10 indexed citations
10.
Han, Dong, Susan Patalano, Shuai Gao, et al.. (2021). Susceptibility-Associated Genetic Variation in NEDD9 Contributes to Prostate Cancer Initiation and Progression. Cancer Research. 81(14). 3766–3776. 4 indexed citations
11.
Zhou, Feng, Shuai Gao, Dong Han, et al.. (2019). TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells. Oncogene. 38(22). 4397–4411. 33 indexed citations
12.
Patalano, Susan, et al.. (2018). CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled To Cullin-RING Ubiquitin Ligase Activation. Scientific Reports. 8(1). 3499–3499. 12 indexed citations
13.
Patalano, Susan, et al.. (2016). CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling. PLoS ONE. 11(7). e0159490–e0159490. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro Oliveira Breakdown of academic impact, for papers by Ojasvi Chaudhary Breakdown of academic impact, for papers by Yuman He Breakdown of academic impact, for papers by Eliot Linton Breakdown of academic impact, for papers by Zixin Guo Breakdown of academic impact, for papers by France‐Hélène Joncas Breakdown of academic impact, for papers by Hai Jiang Breakdown of academic impact, for papers by Rebiguli Aji Breakdown of academic impact, for papers by Jinyeong Lim Breakdown of academic impact, for papers by Hai Tao Wang
Rankless by CCL
2026